Abram SV, Roach BJ, Fryer SL, Calhoun VD, Preda A, van Erp TGM, Bustillo JR, Lim KO, Loewy RL, Stuart BK, Krystal JH, Ford JM, Mathalon DH. Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia. Mol Psychiatry. 2022 Apr 14.
2022
https://researcherprofiles.org/profile/285688012
35422467
Contact us
675 18th St, 4th Floor
San Francisco, CA 94107
Phone: (415) 476-7278
Email: [email protected]
Email Us
Is the Path Program right for you?
Answer a few confidential questions about your mental health to help determine whether the Path Program or current research opportunities may be a fit for you.
Support Our Work
Medium: Digital collage
We are honored to feature the artwork of participants from our program and similar programs across our website. View more from our recent art show, Extreme states and Everything In Between.